Why IMU is a multi multi bagger, page-21529

Yes, absolutely. I know that the majority of shareholders holders do not keep up with dilution for whatever reason. However that doesn't change anything - if you invest in biotech you either acknowledge the need to keep up to avoid dilution, or you have your head in the sand and don't know what you are investing in. I'm not saying that if you can't keep up you have your head in the sand, everyone's circumstances are different. I'm simply referring to that being the biotech cycle. It might sound cold, but this is why it's important to do your own research.

And just for the record, for people who have not been able to keep up with dilution, it is my very strong opinion that the value (not price) of their holding has still benefited enormously from what the dilution has accomplished. Irrespective of their holding size and dilution, if one is prepared to hold, investing in Imugene is a financially sound decision imo.